ORTIN LABORATORIES LTD.

NSE : ORTINLABBSE : 539287ISIN CODE : INE749B01020Industry : Pharmaceuticals & DrugsHouse : Private
BSE19.500.4 (+2.09 %)
PREV CLOSE ( ) 19.10
OPEN PRICE ( ) 18.90
BID PRICE (QTY) 19.66 (1)
OFFER PRICE (QTY) 19.74 (1)
VOLUME 2962
TODAY'S LOW / HIGH ( )18.90 19.99
52 WK LOW / HIGH ( )16.15 30.33
NSE19.600.45 (+2.35 %)
PREV CLOSE( ) 19.15
OPEN PRICE ( ) 19.20
BID PRICE (QTY) 19.50 (221)
OFFER PRICE (QTY) 19.75 (209)
VOLUME 7926
TODAY'S LOW / HIGH( ) 18.55 19.80
52 WK LOW / HIGH ( )16.2 30.35
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.